2018
Is diabetes mellitus equivalent to atherosclerotic cardiovascular disease from a healthcare cost perspective? Insights from the Medical Expenditure Panel Survey
Feldman DI, Valero-Elizondo J, Salami JA, Rana JS, Ogunmoroti O, Okunrintemi V, Osondu CU, Spatz ES, Virani SS, Blankstein R, Blaha MJ, Veledar E, Nasir K. Is diabetes mellitus equivalent to atherosclerotic cardiovascular disease from a healthcare cost perspective? Insights from the Medical Expenditure Panel Survey. Cardiovascular Endocrinology & Metabolism 2018, 7: 64-67. PMID: 31646284, PMCID: PMC6739895, DOI: 10.1097/xce.0000000000000151.Peer-Reviewed Original ResearchAtherosclerotic cardiovascular diseaseDiabetes mellitusMedical Expenditure Panel SurveyCardiovascular diseaseMajor adverse cardiac eventsAggressive therapeutic managementAdverse cardiac eventsLower healthcare expendituresCardiac eventsSecondary preventionTherapeutic managementHealthcare costsEconomic burdenProper lifestyleHealthcare expendituresHousehold ComponentMellitusPanel SurveyDiseasePriority conditionsResource utilizationCliniciansDiagnosisIndividualsPrevention
2017
Primary Prevention with Statins: Strategies to Support Shared Decision-Making
Spatz E, Montori V. Primary Prevention with Statins: Strategies to Support Shared Decision-Making. Current Cardiovascular Risk Reports 2017, 11: 29. DOI: 10.1007/s12170-017-0556-3.Peer-Reviewed Original ResearchStatin therapyPrimary preventionAmerican Heart Association guidelinesPreventive statin therapyHeart Association guidelinesPrimary care cliniciansPatient-centered modelCare cliniciansGuideline recommendationsCholesterol managementLifelong medicationPatient preferencesAssociation guidelinesCardiovascular diseaseClinicians' knowledgeAmerican CollegeHealthcare teamHealth systemPatientsScientific evidenceReviewThis paperTherapyCliniciansPreventionMedications